Literature DB >> 28104818

Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.

Simon A Mortensen1, Bjoern Sander2, Rasmus K Jensen3, Jan Skov Pedersen4, Monika M Golas1, Jens C Jensenius1, Annette G Hansen1, Steffen Thiel1, Gregers R Andersen5.   

Abstract

The complement system is an important antimicrobial and inflammation-generating component of the innate immune system. The classical pathway of complement is activated upon binding of the 774-kDa C1 complex, consisting of the recognition molecule C1q and the tetrameric protease complex C1r2s2, to a variety of activators presenting specific molecular patterns such as IgG- and IgM-containing immune complexes. A canonical model entails a C1r2s2 with its serine protease domains tightly packed together in the center of C1 and an intricate intramolecular reaction mechanism for activation of C1r and C1s, induced upon C1 binding to the activator. Here, we show that the serine protease domains of C1r and C1s are located at the periphery of the C1r2s2 tetramer both when alone or within the nonactivated C1 complex. Our structural studies indicate that the C1 complex adopts a conformation incompatible with intramolecular activation of C1, suggesting instead that intermolecular proteolytic activation between neighboring C1 complexes bound to a complement activating surface occurs. Our results rationalize how a multitude of structurally unrelated molecular patterns can activate C1 and suggests a conserved mechanism for complement activation through the classical and the related lectin pathway.

Entities:  

Keywords:  complement; innate immunity; proteolytic cascade; structural biology

Mesh:

Substances:

Year:  2017        PMID: 28104818      PMCID: PMC5293073          DOI: 10.1073/pnas.1616998114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.

Authors:  Isabelle Bally; Sarah Ancelet; Christine Moriscot; Florence Gonnet; Alberto Mantovani; Régis Daniel; Guy Schoehn; Gérard J Arlaud; Nicole M Thielens
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.

Authors:  Monika Budayova-Spano; Monique Lacroix; Nicole M Thielens; Gérard J Arlaud; Juan Carlos Fontecilla-Camps; Christine Gaboriaud
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.

Authors:  T Y Lin; D S Fletcher
Journal:  J Biol Chem       Date:  1980-08-25       Impact factor: 5.157

4.  Activation of the first component of human complement (C1) by antibody-antigen aggregates.

Authors:  A W Dodds; R B Sim; R R Porter; M A Kerr
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

5.  Structural insights into the initiating complex of the lectin pathway of complement activation.

Authors:  Troels R Kjaer; Le T M Le; Jan Skov Pedersen; Bjoern Sander; Monika M Golas; Jens Christian Jensenius; Gregers R Andersen; Steffen Thiel
Journal:  Structure       Date:  2015-01-08       Impact factor: 5.006

6.  Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.

Authors:  N M Thielens; C Illy; I M Bally; G J Arlaud
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

7.  Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes.

Authors:  Søren E Degn; Troels R Kjaer; Rune T Kidmose; Lisbeth Jensen; Annette G Hansen; Mustafa Tekin; Jens C Jensenius; Gregers R Andersen; Steffen Thiel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

8.  Complement is activated by IgG hexamers assembled at the cell surface.

Authors:  Christoph A Diebolder; Frank J Beurskens; Rob N de Jong; Roman I Koning; Kristin Strumane; Margaret A Lindorfer; Marleen Voorhorst; Deniz Ugurlar; Sara Rosati; Albert J R Heck; Jan G J van de Winkel; Ian A Wilson; Abraham J Koster; Ronald P Taylor; Erica Ollmann Saphire; Dennis R Burton; Janine Schuurman; Piet Gros; Paul W H I Parren
Journal:  Science       Date:  2014-03-14       Impact factor: 47.728

9.  Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY).

Authors:  Clement E Blanchet; Alessandro Spilotros; Frank Schwemmer; Melissa A Graewert; Alexey Kikhney; Cy M Jeffries; Daniel Franke; Daniel Mark; Roland Zengerle; Florent Cipriani; Stefan Fiedler; Manfred Roessle; Dmitri I Svergun
Journal:  J Appl Crystallogr       Date:  2015-03-12       Impact factor: 3.304

Review 10.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

View more
  36 in total

Review 1.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

2.  Reply to Arlaud et al.: Structure of the C1 complex and the unbound C1r2s2 tetramer.

Authors:  Simon A Mortensen; Bjørn Sander; Rasmus K Jensen; Jan S Pedersen; Monika Golas; Jens C Jensenius; Annette G Hansen; Steffen Thiel; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

3.  Structure of the C1 complex of complement.

Authors:  Gérard J Arlaud; Christine Gaboriaud; Wai Li Ling; Nicole M Thielens
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

4.  Models of the complement C1 complex.

Authors:  Simon A Mortensen; Bjørn Sander; Rasmus K Jensen; Jan S Pedersen; Monika M Golas; Steffen Thiel; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-13       Impact factor: 11.205

5.  Reply to Mortensen et al.: The zymogen form of complement component C1.

Authors:  Jamal O M Almitairi; Umakhanth Venkatraman Girija; Christopher M Furze; Xanthe Simpson-Gray; Farah Badakshi; Jamie E Marshall; Wilhelm J Schwaeble; Daniel A Mitchell; Peter C E Moody; Russell Wallis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-13       Impact factor: 11.205

Review 6.  Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Authors:  Jayne L Chamberlain; Saif Huda; Daniel H Whittam; Marcelo Matiello; B Paul Morgan; Anu Jacob
Journal:  J Neurol       Date:  2019-09-03       Impact factor: 4.849

Review 7.  COVID-19: Complement, Coagulation, and Collateral Damage.

Authors:  Martin W Lo; Claudia Kemper; Trent M Woodruff
Journal:  J Immunol       Date:  2020-07-22       Impact factor: 5.422

8.  Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus.

Authors:  Nicole D Schartz; Alexandra L Sommer; Samantha A Colin; Loyda B Mendez; Amy L Brewster
Journal:  Physiol Behav       Date:  2019-10-16

Review 9.  New insights into the immune functions of complement.

Authors:  Edimara S Reis; Dimitrios C Mastellos; George Hajishengallis; John D Lambris
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

Review 10.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.